BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
See today's BioWorld Asia
Home
» Other news to note for Sept. 1, 2020
To read the full story,
subscribe
or
sign in
.
Other news to note for Sept. 1, 2020
Sep. 1, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Akers, Almirall, Altimmune, Ascentage, Astrazeneca, Beigene, Beximco, Bharat Biotech International, Bioage Labs, Biocryst, Biontech, Clinuvel, Elixiron Immunotherapeutics, Fosun Industrial, Heat Biologics, Hitgen, Immutep, Jacobson, Kalos, Mannin Research, Moderna, Novavax, Oncology Venture, Otsuka, Pluristem, Premas, Proteus Digital Health, PT Bio Farma, Q Biomed, Qualigen, Resverlogix, Serum Institute of India, Shanghai Fosun, Singlomics (Beijing Danxu), Sinovac, Starpharma Holdings, Takeda, Therapure, Tyme Technologies, University of Melbourne, Vaccitech, VBI Vaccines.
BioWorld Asia
Briefs
Other news to note